Fan Wu

20210408580, Dec 30, 2021

Nov 26, 2019

17/297228

- Cambridge MA, US
William FITZHUGH - Somerville MA, US
Fan WU - Cambridge MA, US
Xin LI - Belmont MA, US

President and Fellows of Harvard College - Cambridge MA

H01M 10/0562
H01M 4/505
H01M 4/485
H01M 4/58
H01M 10/0525
H01M 10/44
H01M 4/525

The invention provides rechargeable batteries including a solid state electrolyte (SSE) containing an alkali metal disposed between two electrodes. The batteries are volumetrically constrained imparting increased stability under voltage cycling conditions, e.g., through microstructure mechanical constriction on the solid state electrolyte and the electrolyte-electrode interface. These batteries of the invention are advantageous as they may be all-solid-state batteries, e.g., no liquid electrolytes are necessary, and can achieve higher voltages with minimal electrolyte degradation.

20200350618, Nov 5, 2020

Nov 21, 2018

16/766393

- Cambridge MA, US
Fan WU - Cambridge MA, US
William FITZHUGH - Somerville MA, US

H01M 10/0562
H01M 10/0525

The invention provides compositions containing a solid state electrolyte (SSE) containing an alkali metal and a sulfide for use as the electrolyte matrix in a solid state rechargeable battery. The SSE compositions may further contain phosphorous, silicon, or a dopant atom, such as a halogen. These compositions are advantageous as they use Earth-abundant elements, have high voltage stability, excellent battery cycle performance, and are fabricated and used under conditions that do not require excessive external pressures which would otherwise limit their use in a production battery. In particular, the SSEs have a controllable microstructure, e.g., core-shell structure, that enhances their inherent stability while obviating the need for excessively large pressures to control the electrolyte stability. Methods of producing the compositions and rechargeable batteries including the composition are also provided.

20190233431, Aug 1, 2019

Dec 1, 2016

15/777221

- Shanghai, CN
Fan WU - Brookline MA, US

C07D 495/04
A61P 35/00

Compounds having the general formula I or III, and pharmaceutical compositions comprising the same. The compounds of the present invention are useful as selective mutant epidermal growth factor receptor tyrosine kinase (EGFR-TK) inhibitor, and for the treatment of EGFR related diseases and disorders such as cancer.

20180346479, Dec 6, 2018

Dec 2, 2016

15/780239

- Shanghai, CN
Fan WU - Brookline MA, US
Zhanggui WU - Boston MA, US

SHANGHAI AEON BIOTECH CO., LTD. - Shanghai

C07D 495/04

Compounds having the general formula (I) and pharmaceutical compositions that can be used as Bruton's Tyrosine Kinase (BTK), ITK, JAK3, and selective mutant epidermal growth factor receptor tyrosine kinase (EGFR-TK) inhibitor and their uses in the treatment of related diseases and disorders such as cancer.

20160012646, Jan 14, 2016

Jul 10, 2014

14/328293

- Wilmington DE, US
Fan Wu - Malden MA, US
Weitao Wang - Malden MA, US

G06T 19/20
G06T 17/00
G06T 5/00
H04L 29/08

In some aspects, the disclosure is directed methods and systems for constructing a three dimensional (3D) color representation of an object. A first sensor may acquire a first depth image and a first color image of an object from a first angle relative to the object. A second sensor may acquire a second depth image and a second color image of the object from a second angle relative to the object. A processor may map color information from pixels of the first color image to pixels of the first depth image to form a first 3D distribution of colored points representing a first surface portion of the object. The processor may map color information from pixels of the second color image to pixels of the second depth image to form a second 3D distribution of colored points representing a second surface portion of the object. The processor may match, based on 3D structure, a portion of the first 3D distribution of colored points, to a portion of the second 3D distribution of colored points.